Intrapatient variation of aminoglycoside pharmacokinetics in critically ill surgery patients. 1988

D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
University of Minnesota Hospital, Minneapolis.

Intrapatient variation in aminoglycoside pharmacokinetics was studied in 100 critically ill surgery patients, and the relationships between aminoglycoside pharmacokinetics and physiological variables were evaluated. A one-compartment model and the DataMed Clinical Support Service System were used to calculate pharmacokinetic values from serum concentration-time data and to provide individualized dosage regimens. A total of 323 pharmacokinetic analyses (2 to 9 per patient) were performed. There were significant intrapatient differences in clearance (CL) between analyses, and there was a downward trend in elimination rate constant (k) and an upward trend in half-life (t1/2) with time. There were no significant differences in mean volume of distribution (V) between analyses and no strong correlations of V, k, and CL between analyses. The total daily dosage necessary to provide the desired serum aminoglycoside concentration decreased with time, while the dosing interval increased. The mean absolute changes in t1/2, V, and CL between analyses were 3.2 hr, 7.1 L, and 15.7 mL/min, respectively. Dosing regimen changes were required in 90% of the patients, regardless of the time between analyses, including 75% (24/32) of the patients with analyses on consecutive days. There were weak correlations between changes in serum creatinine concentration and changes in dosing interval and between changes in weight and changes in V. Changes in calculated creatinine clearance, BUN, pulmonary capillary wedge pressure, central venous pressure, systemic vascular resistance, cardiac index, input minus output, and maximum temperature did not result in strong correlations with k, t1/2, V, and CL by univariate or multivariate regression analyses.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003422 Critical Care Health care provided to a critically ill patient during a medical emergency or crisis. Intensive Care,Intensive Care, Surgical,Surgical Intensive Care,Care, Critical,Care, Intensive,Care, Surgical Intensive
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
April 1988, Critical care medicine,
D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
November 1988, Anaesthesia and intensive care,
D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
June 2023, The Annals of pharmacotherapy,
D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
December 2020, Surgical infections,
D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
January 1987, Clinical pharmacy,
D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
December 2008, Therapeutic drug monitoring,
D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
January 1979, Journal of medicine,
D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
January 1998, Pharmacotherapy,
D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
November 1992, Critical care medicine,
D W Fuhs, and H J Mann, and C A Kubajak, and F B Cerra
December 1984, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!